Authors:
COSIVI O
GRANGE JM
DABORN CJ
RAVIGLIONE MC
FUJIKURA T
COUSINS D
ROBINSON RA
HUCHZERMEYER HFAK
DEKANTOR I
MESLIN FX
Citation: O. Cosivi et al., ZOONOTIC TUBERCULOSIS DUE TO MYCOBACTERIUM-BOVIS IN DEVELOPING-COUNTRIES, EMERGING INFECTIOUS DISEASES, 4(1), 1998, pp. 59-70
Authors:
GROSSET J
LOUNIS N
TRUFFOTPERNOT C
OBRIEN RJ
RAVIGLIONE MC
JI BH
Citation: J. Grosset et al., ONCE-WEEKLY RIFAPENTINE-CONTAINING REGIMENS FOR TREATMENT OF TUBERCULOSIS IN MICE, American journal of respiratory and critical care medicine, 157(5), 1998, pp. 1436-1440
Authors:
SCHWOEBEL V
PERROCHEAU A
VEEN J
RIEDER HL
RAVIGLIONE MC
Citation: V. Schwoebel et al., IMPROVED BACTERIOLOGICAL DATA ARE NEEDED TO GIVE UNIFORM REPORTING OFTUBERCULOSIS IN EUROPE, BMJ. British medical journal, 316(7142), 1998, pp. 1458-1458
Authors:
PABLOSMENDEZ A
RAVIGLIONE MC
LASZLO A
BINKIN N
RIEDER HL
BUSTREO F
COHN DL
LAMBREGTSVANWEEZENBEEK CSB
KIM SJ
CHAULET P
NUNN P
Citation: A. Pablosmendez et al., GLOBAL SURVEILLANCE FOR ANTITUBERCULOSIS-DRUG RESISTANCE, 1994-1997, The New England journal of medicine, 338(23), 1998, pp. 1641-1649
Authors:
SAWERT H
GIRARDI E
ANTONUCCI G
RAVIGLIONE MC
VIALE P
IPPOLITO G
Citation: H. Sawert et al., PREVENTIVE THERAPY FOR TUBERCULOSIS IN HIV-INFECTED PERSONS - ANALYSIS OF POLICY OPTIONS BASED ON TUBERCULIN STATUS AND CD4(+) CELL COUNT, Archives of internal medicine, 158(19), 1998, pp. 2112-2121
Authors:
DROBNIEWSKI F
PABLOSMENDEZ A
RAVIGLIONE MC
Citation: F. Drobniewski et al., EPIDEMIOLOGY OF TUBERCULOSIS IN THE WORLD, Seminars in respiratory and critical care medicine, 18(5), 1997, pp. 419-429
Citation: Dl. Cohn et al., DRUG-RESISTANT TUBERCULOSIS - REVIEW OF THE WORLDWIDE SITUATION AND THE WHO IUATLD GLOBAL SURVEILLANCE PROJECT/, Clinical infectious diseases, 24, 1997, pp. 121-130
Authors:
MAHER D
HAUSLER HP
RAVIGLIONE MC
KALEEBA N
AISU T
FOURIE B
NUNN P
Citation: D. Maher et al., TUBERCULOSIS CARE IN COMMUNITY CARE ORGANIZATIONS IN SUB-SAHARAN AFRICA - PRACTICE AND POTENTIAL, The international journal of tuberculosis and lung disease, 1(3), 1997, pp. 276-283
Authors:
SAWERT H
KONGSIN S
PAYANANDANA V
AKARASEWI P
NUNN PP
RAVIGLIONE MC
Citation: H. Sawert et al., COSTS AND BENEFITS OF IMPROVING TUBERCULOSIS-CONTROL - THE CASE OF THAILAND, Social science & medicine, 44(12), 1997, pp. 1805-1816
Authors:
GIRARDI E
ANTONUCCI G
IPPOLITO G
RAVIGLIONE MC
RAPITI E
DIPERRI G
BABUDIERI S
ALMI P
ANGARANO G
ARMIGNACCO O
BEVILACQUA N
BINI A
BOTTURA P
BOUMIS E
COSTIGLIOLA P
ERRANTE I
LIBANORE M
LIUZZI G
MANZILLO E
MINOLI L
NARCISO P
PAGANO G
PELLIZZER G
RUSCONI S
SANTORO D
SAVALLI E
TAVIO M
TRAVERSO A
VIALE P
Citation: E. Girardi et al., ASSOCIATION OF TUBERCULOSIS RISK WITH THE DEGREE OF TUBERCULIN REACTION IN HIV-INFECTED PATIENTS, Archives of internal medicine, 157(7), 1997, pp. 797-800
Authors:
MIGLIORI GB
SPANEVELLO A
BALLARDINI L
NERI M
GAMBARINI C
MORO ML
TRNKA L
RAVIGLIONE MC
Citation: Gb. Migliori et al., VALIDATION OF THE SURVEILLANCE SYSTEM FOR NEW CASES OF TUBERCULOSIS IN A PROVINCE OF NORTHERN ITALY, The European respiratory journal, 8(8), 1995, pp. 1252-1258
Authors:
AISU T
RAVIGLIONE MC
VANPRAAG E
ERIKI P
NARAIN JP
BARUGAHARE L
TEMBO G
MCFARLAND D
ENGWAU FA
Citation: T. Aisu et al., PREVENTIVE CHEMOTHERAPY FOR HIV-ASSOCIATED TUBERCULOSIS IN UGANDA - AN OPERATIONAL ASSESSMENT AT A VOLUNTARY COUNSELING AND TESTING CENTER, AIDS, 9(3), 1995, pp. 267-273
Citation: Mc. Raviglione et al., TUBERCULOSIS TREATMENT IN DEVELOPING-NATIONS - REPLY, JAMA, the journal of the American Medical Association, 274(2), 1995, pp. 125-126
Authors:
ANTONUCCI G
GIRARDI E
RAVIGLIONE MC
IPPOLITO G
Citation: G. Antonucci et al., RISK-FACTORS FOR TUBERCULOSIS IN HIV-INFECTED PERSONS - A PROSPECTIVECOHORT STUDY, JAMA, the journal of the American Medical Association, 274(2), 1995, pp. 143-148
Citation: Mc. Raviglione et al., GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS - MORBIDITY AND MORTALITY OF A WORLDWIDE EPIDEMIC, JAMA, the journal of the American Medical Association, 273(3), 1995, pp. 220-226
Authors:
CHAPUIS L
JI BH
TRUFFOTPERNOT C
OBRIEN RJ
RAVIGLIONE MC
GROSSET JH
Citation: L. Chapuis et al., PREVENTIVE THERAPY OF TUBERCULOSIS WITH RIFAPENTINE IN IMMUNOCOMPETENT AND NUDE-MICE, American journal of respiratory and critical care medicine, 150(5), 1994, pp. 1355-1362
Authors:
JI BH
TRUFFOTPERNOT C
LACROIX C
RAVIGLIONE MC
OBRIEN RJ
OLLIARO P
ROSCIGNO G
GROSSET J
Citation: Bh. Ji et al., EFFECTIVENESS OF RIFAMPIN, RIFABUTIN, AND RIFAPENTINE FOR PREVENTIVE THERAPY OF TUBERCULOSIS IN MICE (VOL 148, PG 1541, 1993), American journal of respiratory and critical care medicine, 150(2), 1994, pp. 598-598
Citation: Pj. Dolin et Mc. Raviglione, ESTIMATES OF FUTURE GLOBAL TUBERCULOSIS MORBIDITY AND MORTALITY (REPRINTED FROM MMWR, VOL 42, PG 961, 1993), JAMA, the journal of the American Medical Association, 271(10), 1994, pp. 739-741